Please use this identifier to cite or link to this item: http://dspace.nuph.edu.ua/handle/123456789/14124
Title: Synthesis of 2-(4-aryl(adamantyl)-2-phenylіmіnothіazol-3-yl)-ethanol derivatives and prediction of their biological activity
Authors: Yeromina, H. O.
Drapak, I. V.
Perekhoda, L. O.
Yaremenko, V. D.
Demchenko, A. M.
Єрьоміна, Г. О.
Еремина, А. А.
Драпак, І. В.
Драпак, И. В.
Перехода, Л. А.
Яременко, В. Д.
Демченко, А. М.
Keywords: 1,3-thiazole derivatives;synthesis;«drug-likeness»;virtual screening
Issue Date: 2016
Publisher: Der Pharma Chemica, 2016, 8(3):64-70
Bibliographic description (Ukraine): Synthesis of 2-(4-aryl(adamantyl)-2-phenylіmіnothіazol-3-yl)-ethanol derivatives and prediction of their biological activity / H. O. Yeromina, I. V. Drapak, L. O. Perekhoda, V. D. Yaremenkom, A. M. Demchenko // Der Pharma Chemica. - 2016. - № 8 (3). - С. 64-70.
Abstract: The synthesis of new 2-(4-aryl(adamantyl)-2-phenylіmіnothіazol-3-yl)-ethanol derivatives has been carried out. The structures and purity of synthesized compounds were verified on the basis of elemental analysis, 1Н NMRspectroscopy and chromatography-mass spectrometry. To optimize the pharmacological screening of 2-(4- aryl(adamantyl)-2-phenylіmіnothіazol-3-yl)-ethanol derivatives «drug-like» parameters have been calculated and simulation of biological properties has been done. It was established that 13 synthesized compounds comply with Lipinski's Rule of Five and can be recommended for experimental biological tests. Based on data PASS-prediction as priority directions for experimental trials screening for anti-ischemic and anti-inflammatory activity has been chosen. The most perspective substances for experimental biological tests were elected.
URI: http://dspace.nuph.edu.ua/handle/123456789/14124
ISSN: 0975-413X
Appears in Collections:Наукові публікації кафедри медичної хiмiї

Files in This Item:
File Description SizeFormat 
DPC-2016-8-3-64-70.pdf125,53 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.